Core protein mutations are key determinants of hepatitis B virus replication during the hepatitis B e antigen-negative stage. [PDF]
Flichman D +4 more
europepmc +1 more source
Therapeutic vaccination strategy targeting the PreS1 region of L-HBsAg for HBV/HDV co-infection. [PDF]
Russell RA +11 more
europepmc +1 more source
Hepatitis B : are you at risk? [Hmong]
Hepatitis B : are you at risk? [Hmong]Hmong Publication No. 221613These sheets have the English translation on the back.cdc/gov/knowhepatitisBFactSheet-HepBAreYouAtRisk_hmg ...
core
Decoding HBV-specific adaptive immunity: from natural clearance to cure. [PDF]
Thimme R +3 more
europepmc +1 more source
Progress and challenge of hepatitis B virus mucosal vaccines. [PDF]
Renxuan J, Hongxiang L, Daru L.
europepmc +1 more source
Complete remission of minimal change disease after antiviral monotherapy in a patient with immune-active chronic hepatitis B: A case report. [PDF]
Lee TW +7 more
europepmc +1 more source
Long-term antigen reduction does not achieve durable HBV control in mice but enhances therapeutic vaccine efficacy. [PDF]
Michler T +9 more
europepmc +1 more source
Chronic Hepatitis B in the United States: Current Landscape, Unmet Needs and Future Directions. [PDF]
Cohen C, Esteban JP, Bobde S, Wong RJ.
europepmc +1 more source
Feasibility, Accuracy, and Acceptability of Self-Collected Dried Blood Spots for Hepatitis C Virus, Hepatitis B Virus, and SARS-CoV-2 Testing. [PDF]
Tran SS +15 more
europepmc +1 more source
A preS2 aa1-26-specific humoural response marks functional cure in chronic HBV infection. [PDF]
Wang YY +23 more
europepmc +1 more source

